✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DiabetesCardiovascularCbdCardioprotectionPreclinical Why This MattersDiabetic cardiomyopathy affects up to 60% of diabetic patients and lacks...
CBD Oil for Neuropathy: Is it a Safe Option for Diabetics? | Ubie Doctor’s Note
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic NeuropathyDiabetesCbdPain ManagementDrug Interactions Why This MattersDiabetic neuropathy affects up to 50% of diabetic patients...
Can Marijuana Lower Blood Sugar Levels? What the Evidence Actually Shows
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DiabetesMetabolismGlucose ControlDrug InteractionsEvidence-Based Medicine Why This MattersDiabetes affects over 37 million Americans, and patients...
High-Risk Behavior? What Your Patients Should Know About Cannabis and Diabetes
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DiabetesMetabolismPatient SafetyDrug InteractionsGlucose Control Why This MattersCannabis use is increasingly common among patients with...
CBD Gummies That Help Diabetes: What the Evidence Shows and How to Approach Them
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DiabetesCbdNeuropathyDrug InteractionsEvidence-Based Medicine Why This MattersPatients with diabetes increasingly ask about CBD for glucose...
Rachael Ray CBD gummies for diabetes: a realistic look at the claims and the evidence
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DiabetesCbdMarketing ClaimsDrug InteractionsGlucose Control Why This MattersCelebrity-endorsed CBD products for diabetes represent a growing...
Letter by Wu et al Regarding Article, “G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice”.
CED Clinical Relevance #56Monitored Relevance Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch | CED Clinic DiabetesCardiovascularCb2MechanismResearch JournalCirculationStudy TypeClinical StudyPopulationHuman participants Why This MattersThis mechanistic research illuminates how cannabinoid receptor 2 (CB2)...
Cannabis may treat or prevent type II diabetes
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DiabetesMetabolismCbdInsulinEndocrine Why This MattersType 2 diabetes affects over 37 million Americans, and any therapeutic...
How N-Acylethanolamines Control Appetite, Energy Balance, and Metabolic Health
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyMetabolism Why This Matters Understanding how N-acylethanolamines regulate appetite and metabolic pathways provides clinicians with...
Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchMental HealthSafety Why This Matters Clinicians treating patients with obesity or diabetes who are prescribed...